Potent and selective α-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase

被引:72
|
作者
Romero, F. Anthony
Du, Wu
Hwang, Inkyu
Rayl, Thomas J.
Kimball, F. Scott
Leung, Donmienne
Hoover, Heather S.
Apodaca, Richard L.
Breitenbucher, J. Guy
Cravatt, Benjamin F.
Boger, Dale L.
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA
关键词
D O I
10.1021/jm0611509
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A study of the structure-activity relationships (SAR) of 2f (OL-135), a potent inhibitor of fatty acid amide hydrolase (FAAH), is detailed, targeting the 5-position of the oxazole. Examination of a series of substituted benzene derivatives (12-14) revealed that the optimal position for substitution was the meta-position with selected members approaching or exceeding the potency of 2f. Concurrent with these studies, the effect of substitution on the pyridine ring of 2f was also examined. A series of small, nonaromatic C5-substituents was also explored and revealed that the K-i follows a well-defined correlation with the Hammett sigma(p) constant (rho = 3.01, R-2 = 0.91) in which electron-withdrawing substituents enhance potency, leading to inhibitors with K(i)s as low as 400 pM (20n). Proteomic-wide screening of the inhibitors revealed that most are exquisitely selective for FAAH over all other mammalian proteases, reversing the 100-fold preference of 20a (C5 substituent = H) for the enzyme TGH.
引用
收藏
页码:1058 / 1068
页数:11
相关论文
共 50 条
  • [31] Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH)
    Timmons, Amy
    Seierstad, Mark
    Apodaca, Rich
    Epperson, Matt
    Pippel, Dan
    Brown, Sean
    Chang, Leon
    Scott, Brian
    Webb, Michael
    Chaplan, Sandra R.
    Breitenbucher, J. Guy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 2109 - 2113
  • [32] Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception
    Naidu, Pattipati S.
    Booker, Lamont
    Cravatt, Benjamin F.
    Lichtman, Aron H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01): : 48 - 56
  • [33] Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis
    Rieck, Sarah
    Kilgus, Sofia
    Meyer, Johanna H.
    Huang, Hao
    Zhao, Lan
    Matthey, Michaela
    Wang, Xin
    Schmitz-Valckenberg, Steffen
    Fleischmann, Bernd K.
    Wenzel, Daniela
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (12) : 2974 - 2989
  • [34] Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
    Keith, John M.
    Apodaca, Richard
    Xiao, Wei
    Seierstad, Mark
    Pattabiraman, Kanaka
    Wu, Jiejun
    Webb, Michael
    Karbarz, Mark J.
    Brown, Sean
    Wilson, Sandy
    Scott, Brian
    Tham, Chui-Se
    Luo, Lin
    Palmer, James
    Wennerholm, Michelle
    Chaplan, Sandra
    Breitenbucher, J. Guy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4838 - 4843
  • [35] Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase
    Haller, Victoria L.
    Stevens, David L.
    Welch, Sandra P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 600 (1-3) : 50 - 58
  • [36] Novel propanamides as fatty acid amide hydrolase inhibitors
    Deplano, Alessandro
    Morgillo, Carmine Marco
    Demurtas, Monica
    Bjorklund, Emmelie
    Cipriano, Mariateresa
    Svensson, Mona
    Hashemian, Sanaz
    Smaldone, Giovanni
    Pedone, Emilia
    Javier Luque, F.
    Cabiddu, Maria G.
    Novellino, Ettore
    Fowler, Christopher J.
    Catalanotti, Bruno
    Onnis, Valentina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 136 : 523 - 542
  • [37] Optimization of α-ketooxazole inhibitors of fatty acid amide hydrolase
    Kimball, F. Scott
    Romero, F. Anthony
    Ezzili, Cyrine
    Garfunkle, Joie
    Rayl, Thomas J.
    Hochstatter, Dustin G.
    Hwang, Inkyu
    Boger, Dale L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 937 - 947
  • [38] Fatty acid amide hydrolase inhibitors and the marijuana debate
    Gurwitz, D
    Weizman, A
    LANCET, 2001, 358 (9292): : 1548 - 1548
  • [39] Fatty Acid Amide Hydrolase Inhibitors - Progress and Potential
    Khanna, Ish K.
    Alexander, Christopher W.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 545 - 558
  • [40] Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase
    Alapafuja, Shakiru O.
    Nikas, Spyros P.
    Bharathan, Indu T.
    Shukla, Vidyanand G.
    Nasr, Mahmoud L.
    Bowman, Anna L.
    Zvonok, Nikolai
    Li, Jing
    Shi, Xiaomeng
    Engen, John R.
    Makriyannis, Alexandros
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10074 - 10089